CCC (Consumer Complaints Council) of ASCI upholds complaints on 193 advertisements

The Advertising Standards Council of India (ASCI)’s Consumer Complaints Council (CCC) received 193 complaints out of total 290 advertisements that were passed by the Consumer Complaints Council in February 2018.

ASCI’s Suo Moto surveillance picked up 187 ads and objections on 163 advertisements were upheld.

If we categories complaints according to the sectors then ASCI received 154 objections belongs to the healthcare sector, 18 related to the education sector, 8 relating food & beverages, 2 on personal care and 11 belongs to others category. 103 complaints were made by general public or by the industry members and 30 advertisements were upheld by the CCC itself.

Advertisements made false claims and mislead public with their false claims. Number one reason for complaints was related to the gross exaggeration of product efficacy followed by the violation of the Drugs and Magic Remedies Act (DMR Act) and the Drugs and Cosmetics (D&C) Rules. Advertisements encouraging people to consume snacking products and claims like “instant” result post consumption of a fast absorbing product also considered being misleading.  Enhancing IQ with the use of a leading food company product was inadequately substantiated. Another marketing advertisement that claims the use of their mattress less than six hours of sleep drains 40% of brain energy was considered to be misleading.

Related Posts

Lilly launches Mounjaro KwikPen in India

Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

  Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India